BGB-8035
Product Specifications
CAS Number
2283349-24-4
Target
BTK, EGFR
Related Pathways
JAK/STAT signaling, Angiogenesis, Tyrosine Kinase/Adaptors
Purity
0.9674
Bioactivity
BGB-8035 is an orally available, selective and potent BTK inhibitor with antitumor activity that inhibits BTK, TEC and EGFR.BGB-8035 is used in the study of tumors and autoimmune diseases.
Smiles
C(N)(=O)C1=C2N([C@@H](CCN2)C3CCN(C(C=C)=O)CC3)N=C1C4=CC(OC)=C(C)C(OC)=C4
Molecular Formula
C24H31N5O4
Molecular Weight
453.53
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0235106 1.0 µg DNA
C4orf8 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
Sign In for Pricing
View Details 
MBS6202470-01 0.1 mL
PHTF1 (Putative Homeodomain Transcription Factor 1, PHTF) (MaxLight 490)
Sign In for Pricing
View Details MBS6202470-02 5x 0.1 mL
PHTF1 (Putative Homeodomain Transcription Factor 1, PHTF) (MaxLight 490)
Sign In for Pricing
View Details 
MBS6160761-01 0.1 mL
TNFSF13 (Tumor Necrosis Factor Ligand Superfamily Member 13, A Proliferation-inducing Ligand, APRIL, CD256, TNF- and APOL-related Leukocyte Expressed Ligand 2, TALL2, TALL-2, TNF-related Death Ligand 1, TRDL-1, UNQ383/PRO715, ZTNF2) (PE)
Sign In for Pricing
View Details